LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - ProKidney (NASDAQ: PROK)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ PROK ProKidney
Control Empresarial de Capitales S.A. de C.V. / 10 percent owner, other: Add'l Rep. Persons-see Ex.99-1
04/16/2025
Buy
$0.75
100,000
$75K
73.43M
NASDAQ PROK ProKidney
Control Empresarial de Capitales S.A. de C.V. / 10 percent owner, other: Add'l Rep. Persons-see Ex.99-1
04/15/2025
Buy
$0.70
468,000
$326K
73.33M
NASDAQ PROK ProKidney
Control Empresarial de Capitales S.A. de C.V. / 10 percent owner, other: Add'l Rep. Persons-see Ex.99-1
04/14/2025
Buy
$0.73
268,105
$195K
72.86M
NASDAQ PROK ProKidney
Control Empresarial de Capitales S.A. de C.V. / 10 percent owner, other: Add'l Rep. Persons-see Ex.99-1
04/11/2025
Buy
$0.61
1,900
$1K
72.59M
NASDAQ PROK ProKidney
Control Empresarial de Capitales S.A. de C.V. / 10 percent owner, other: Add'l Rep. Persons-see Ex.99-1
04/10/2025
Buy
$0.61
1.03M
$628K
72.59M
NASDAQ PROK ProKidney
Culleton Bruce / director, officer: Chief Executive Officer
03/01/2025
Buy
$1.23
1.80M
$2.209M
1.80M
NASDAQ PROK ProKidney
Weber Darin J. / officer: Chief Regulatory Officer
03/01/2025
Buy
$1.23
450,000
$554K
450,000
NASDAQ PROK ProKidney
Girolamo Todd C / officer: Chief Legal Officer
03/01/2025
Buy
$1.23
650,000
$800K
650,000
NASDAQ PROK ProKidney
Coulston James / officer: Chief Financial Officer
03/01/2025
Buy
$1.23
650,000
$800K
650,000